Free Trial

Beximco Pharmaceuticals (LON:BXP) Shares Pass Above 50-Day Moving Average - What's Next?

Beximco Pharmaceuticals logo with Medical background

Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report) shares passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 26.62 ($0.34) and traded as high as GBX 34.50 ($0.44). Beximco Pharmaceuticals shares last traded at GBX 32.50 ($0.42), with a volume of 90,171 shares traded.

Beximco Pharmaceuticals Trading Down 9.3 %

The business has a fifty day moving average of GBX 26.62 and a 200-day moving average of GBX 33.78. The company has a debt-to-equity ratio of 14.73, a quick ratio of 0.37 and a current ratio of 1.80. The company has a market capitalization of £131.47 million, a P/E ratio of 375.00 and a beta of 0.61.

About Beximco Pharmaceuticals

(Get Free Report)

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.

Further Reading

Should you invest $1,000 in Beximco Pharmaceuticals right now?

Before you consider Beximco Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beximco Pharmaceuticals wasn't on the list.

While Beximco Pharmaceuticals currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines